Limited-Time September Offer: Try 7 Days for Free

Evotec SE (EVT.DE) Stock Price

€6.29 1.3%

Sign up
to add to portfolio

AI Score

  • Alternative

    2

  • Fundamental

    2

  • Technical

    5

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Evotec SE, AI stock picks, stock alerts and much more.

Sign up

EVT.DE AI Stock Analysis

AI stock analysis for EVT.DE is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Evotec SE (EVT.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Evotec SE (EVT.DE) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Evotec SE (EVT.DE), currently trading at €6.29, will... Sign up to access price prediction.

About EVT.DE

LSE

  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide.

  • Symbol

    EVT.DE

  • Market

    XETRA

  • Industry

    Drug Manufacturers - Specialty & Generic

  • Market Cap

    1.1B

Similar Stocks

SBX.DE SynBiotic SE
SBX.DE		 €2.84
3.7%
5
APPH.DE Apontis Pharma AG
APPH.DE		 €10.9
0.00%
7
93M1.DE MPH Health Care AG
93M1.DE		 €18.9
1.1%
5
ZOE.DE Zoetis Inc.
ZOE.DE		 €125
2%
6
2HQ.DE Tilray Brands
2HQ.DE		 €1.03
2.1%
4

News

What is HC Wainwright’s Forecast for Evotec FY2027 Earnings?

What is HC Wainwright’s Forecast for Evotec FY2027 Earnings?
April 22, 2025. ETF Daily News
Wellington Management Group LLP Cuts Stock Position in Evotec SE (NASDAQ:EVO)

Wellington Management Group LLP Cuts Stock Position in Evotec SE (NASDAQ:EVO)
April 10, 2025. ETF Daily News
Evotec (NASDAQ:EVO) Sets New 12-Month Low – Time to Sell?

Evotec (NASDAQ:EVO) Sets New 12-Month Low – Time to Sell?
April 8, 2025. ETF Daily News
Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering

Kazia Therapeutics Announces Closing of $2.0 Million Registered Direct Offering
January 14, 2025. Investing.com

EVT.DE Alternative Data

Web Traffic

Evotec SE receives an estimated 128987 monthly visitors to evotec.com.

  • Web Traffic

    128987

  • Change from Previous Month

    26.4%

  • 3 Month Change

    6.8%

  • YoY Change

    6.8%

Twitter Followers

Evotec SE has 4,072 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.3% over the last month.

  • Twitter Followers

    4072

  • Daily Change

    0%

  • 1 Month Change

    0.3%

  • 3 Month Change

    0.1%

  • YoY Change

    0.1%

Youtube Subscribers

Evotec SE has 452 subscribers on its main Youtube channel, up by 1.3% over the last month.

  • Youtube Subscribers

    452

  • Daily Change

    0%

  • 1 Month Change

    1.3%

  • 3 Month Change

    2.3%

  • YoY Change

    2.3%

Job Postings

Evotec SE has an estimated 101 open job postings, which is down -15.8% over the last month.

  • Job Postings

    101

  • Daily Change

    4.1%

  • 1 Month Change

    15.8%

  • 3 Month Change

    9.8%

  • YoY Change

    9.8%

Reddit Mentions

Evotec SE has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

LinkedIn Employees

According to LinkedIn, Evotec SE has 4,893 employees, down by -0.2% over the last month.

  • LinkedIn Employees

    4893

  • Daily Change

    0.2%

  • 1 Month Change

    0.2%

  • 3 Month Change

    0%

  • YoY Change

    0%

Business Outlook

According to employee reviews, the business outlook among employees at Evotec SE is 17 out of 100 (very bearish).

  • Business Outlook

    17

  • Change from Previous Month

    5.6%

  • 3 Month Change

    5.6%

  • YoY Change

    5.6%

News Mentions

Evotec SE was mentioned 1 times in the news yesterday.

  • News Mentions

    1

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

EVT.DE Financials

EVT.DE Key Metrics

  • Total Revenue

    €200M

  • Net Income

    -€31.6M

  • Earnings per Share

    -€0.18

  • Free cash flow

    -€53.6M

  • EBITDA

    -€27.4M

  • EBITDA Ratio

    -0.137235

  • Total Assets

    €1.9B

EVT.DE 2-year Revenue & Income
EVT.DE 2-year Free Cash Flow

EVT.DE Technicals

EVT.DE SMA
EVT.DE RSI

FAQ

What's the current price of Evotec SE (EVT.DE) Stock?
The price of an Evotec SE (EVT.DE) share is €6.29.

What's the market cap of Evotec SE?
The current market cap of Evotec SE is 1.1B.

What are some stocks similar to Evotec SE (EVT.DE) that investors often compare it to?
Evotec SE (EVT.DE) is often compared to similar stocks such as SynBiotic SE, Apontis Pharma AG, MPH Health Care AG, Zoetis Inc. and Tilray Brands.

What is the forecast for Evotec SE's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Evotec SE's stock price to be around €5.57 in 2026. Starting from the current price of €6.29, this represents a 11.5% change in price, indicating a bearish outlook for the stock.

How to buy Evotec SE (EVT.DE) Stock?
Evotec SE stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Evotec SE shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.